Medical equipment manufacturer Mindray Medical International has signed a definitive agreement to acquire the remaining stake in Wuhan Dragonbio Surgical Implant.
The transaction is valued at $72.6 million and could close as soon as this month, Mindray said. Mindray bought a controlling share of the medical orthopedics product provider in 2012.
Mindray plans to make Wuhan Dragonbio, which specializes in trauma, spine, joint, and other surgical products, a wholly owned subsidiary.
